cambridge's bluebird bio licenses delivery tech to novartis, gsk. therapy, hdl particle size got smaller (not a good thing) and the hdl worked less effectively to remove cholesterol from the body," mehta said...
.
. it also provides 85 per cent accurate prediction results than current methods.....